<?xml version="1.0"?>
<rss version="2.0">
	<channel>
		<title>Drug News indicated for Alzheimers disease.</title>
		<link>http://www.lifescience-online.com/</link>
		<description>News Feed Powered by Lifescience-online.com</description>
		<language>en-us</language>
		<pubDate>Thu, 20 Nov 2008 18:42:56 +0100</pubDate>
		<lastBuildDate>Thu, 20 Nov 2008 18:42:56 +0100</lastBuildDate>
		<category>News</category>		

		<image>
			<title>Lifescience-online</title>
			<url>http://rss.lifescience-online.com/images/logo.gif</url>
			<link>http://www.lifescience-online.com/</link>
			<width></width>
			<height></height>
			<description>Lifescience-online</description>
		</image>

		<item>
			<title>Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia</title>
			<link>http://www.lifescience-online.com/Memory_Pharmaceuticals_Achieves_Enrollment_Goal_fo,12908.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/roche_holding,1071.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>ROCHE HOLDING LTD</u></font></a><br /><a href='http://www.lifescience-online.com/memory_pharmaceuticals,6104.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>Memory Pharmaceuticals Corp</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/MEM-3454,21083.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>MEM-3454</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 18 Nov 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>TorreyPines Therapeutics, Inc. Licenses Posiphen(TM), Bisnorcymcerine and Phenserine to QR Pharma</title>
			<link>http://www.lifescience-online.com/TorreyPines_Therapeutics__Inc__Licenses_Posiphen_T,12904.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/1.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/torreypines_therapeutics,6876.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>TORREYPINES THERAPEUTICS INC</u></font></a><br /><a href='http://www.lifescience-online.com/qr_pharma,11042.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>QR PHARMA INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/BISNORCYMSERINE,1130.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>BISNORCYMSERINE</u></font></a><br /><a href='http://www.lifescience-online.com/PHENSERINE,5603.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>PHENSERINE</u></font></a><br /><a href='http://www.lifescience-online.com/POSIPHEN,5657.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>POSIPHEN</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 17 Nov 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Merz Pharmaceuticals&#039; Tinnitus Candidate Enters into Phase III</title>
			<link>http://www.lifescience-online.com/Merz_Pharmaceuticals__Tinnitus_Candidate_Enters_in,12795.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Other...</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/merz_pharmaceuticals,7806.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>MERZ PHARMACEUTICALS</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/NERAMEXANE,5234.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>NERAMEXANE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Wed, 12 Nov 2008 15:23:46 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Intellect Neurosciences, Inc. Validates Pivotal European Patent for Alzheimer&#039;s Monoclonal Antibody Platform</title>
			<link>http://www.lifescience-online.com/Intellect_Neurosciences__Inc__Validates_Pivotal_Eu,12789.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/intellect_neurosciences,9832.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>INTELLECT NEUROSCIENCES INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/BETA-AMYLOID_ANTIBODIES,5330.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>BETA-AMYLOID ANTIBODIES</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 10 Nov 2008 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>TorreyPines Therapeutics Sells Alzheimer&#039;s Disease Genetics Program to Eisai</title>
			<link>http://www.lifescience-online.com/TorreyPines_Therapeutics_Sells_Alzheimer_s_Disease,12706.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/4/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Partnerships and Licensing</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/eisai_co,5572.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>EISAI CO LTD</u></font></a><br /><a href='http://www.lifescience-online.com/torreypines_therapeutics,6876.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>TORREYPINES THERAPEUTICS INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/NGX-267,4723.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>NGX-267</u></font></a><br /><a href='http://www.lifescience-online.com/ALZHEIMER_THERAPY,8560.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>ALZHEIMER THERAPY</u></font></a><br /><a href='http://www.lifescience-online.com/TEZAMPANEL,20360.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>TEZAMPANEL</u></font></a><br /><a href='http://www.lifescience-online.com/NGX-426,21281.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>NGX-426</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 10 Nov 2008 16:06:57 GMT</pubDate>
			<category>News</category>
		</item>

	</channel>
</rss>